Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527392 | SCV000626061 | pathogenic | Ellis-van Creveld syndrome | 2017-08-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu514Argfs*33) in the EVC gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with EVC-related disease. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV001389791 | SCV001591269 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu514Argfs*33) in the EVC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EVC-related conditions. ClinVar contains an entry for this variant (Variation ID: 455998). For these reasons, this variant has been classified as Pathogenic. |
Counsyl | RCV000527392 | SCV001132184 | likely pathogenic | Ellis-van Creveld syndrome | 2017-03-08 | no assertion criteria provided | clinical testing |